Phospholipid compositions for delivery of therapeutic compounds

A lipid formulation for use in therapy by enhancing absorption of a therapeutic ingredient in a subject in need thereof, comprising:

• a) phospholipids from a marine source, wherein the phospholipids comprise more than 80% w/w phosphatidylcholine and wherein the molar content of omega-3 moieties in the phospholipids is more than 25%;
• and
• b) a therapeutic ingredient selected from the group consisting of a substance classified as class 2, 3 or 4 according to the Biopharmaceutical classification system (BCS) and a lipophilic substance from a source different from the marine source for the phospholipids;
• wherein the lipid formulation comprises more than 17% w/w of phospholipids and forms emulsions selected from the group consisting of emulsions with a droplet size of from 150 nm to 600 nm in an artificial stomach fluid determined through dynamic light scattering.